Insider Transactions in Q1 2023 at Inspire Medical Systems, Inc. (INSP)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2023
|
Shawn Mc Cormick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+25.78%
|
$0
$0.94 P/Share
|
|
Mar 08
2023
|
John Rondoni Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,387
+24.56%
|
$8,774
$2.07 P/Share
|
|
Mar 01
2023
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-43.21%
|
$54,230,000
$5423.45 P/Share
|
|
Mar 01
2023
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+49.25%
|
$0
$0.94 P/Share
|
|
Feb 27
2023
|
Steven Jandrich VP, Human Resources |
BUY
Bona fide gift
|
Indirect |
128
+21.12%
|
-
|
|
Feb 27
2023
|
Steven Jandrich VP, Human Resources |
SELL
Bona fide gift
|
Direct |
128
-2.85%
|
-
|
|
Feb 24
2023
|
Steven Jandrich VP, Human Resources |
BUY
Bona fide gift
|
Indirect |
128
+21.12%
|
-
|
|
Feb 24
2023
|
Steven Jandrich VP, Human Resources |
SELL
Bona fide gift
|
Direct |
256
-2.73%
|
-
|
|
Feb 16
2023
|
Philip Ebeling Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,000
-96.65%
|
$1,925,000
$275.0 P/Share
|
|
Feb 16
2023
|
Philip Ebeling Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+49.15%
|
$1,358,000
$194.82 P/Share
|
|
Feb 15
2023
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Open market or private sale
|
Indirect |
11,715
-39.57%
|
$3,221,625
$275.17 P/Share
|
|
Feb 14
2023
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Open market or private sale
|
Indirect |
20,138
-21.14%
|
$5,537,950
$275.82 P/Share
|
|
Feb 13
2023
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Open market or private sale
|
Indirect |
2,619
-21.21%
|
$720,225
$275.05 P/Share
|
|
Feb 09
2023
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Open market or private sale
|
Indirect |
7,028
-36.27%
|
$1,932,700
$275.12 P/Share
|
|
Feb 08
2023
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Open market or private sale
|
Indirect |
3,500
-15.3%
|
$962,500
$275.0 P/Share
|
|
Feb 08
2023
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,500
-11.38%
|
$667,500
$267.5 P/Share
|
|
Feb 06
2023
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,500
-6.32%
|
$875,000
$250.36 P/Share
|
|
Jan 29
2023
|
Bryan K Phillips Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-9.47%
|
$51,865
$253.24 P/Share
|
|
Jan 25
2023
|
Richard Buchholz Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,100
+4.86%
|
$250,100
$41.18 P/Share
|
|
Jan 23
2023
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+9.51%
|
$0
$0.94 P/Share
|
|
Jan 13
2023
|
Richard Buchholz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,977
-25.83%
|
$2,994,250
$250.03 P/Share
|
|
Jan 11
2023
|
Richard Buchholz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
523
-1.12%
|
$130,750
$250.0 P/Share
|
|
Jan 10
2023
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
60
+2.59%
|
$14,880
$248.31 P/Share
|
|
Jan 10
2023
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
55
+12.67%
|
$13,640
$248.31 P/Share
|
|
Jan 10
2023
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
60
+9.92%
|
$14,880
$248.31 P/Share
|
|
Jan 10
2023
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+2.01%
|
$21,080
$248.31 P/Share
|
|
Jan 10
2023
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
52
+0.27%
|
$12,896
$248.31 P/Share
|
|
Jan 10
2023
|
Charisse Y Sparks Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52
+33.55%
|
$12,896
$248.31 P/Share
|
|
Jan 05
2023
|
Richard Buchholz Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
400
+7.55%
|
-
|
|
Jan 05
2023
|
Richard Buchholz Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
400
-0.85%
|
-
|
|
Jan 03
2023
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,170
-7.2%
|
$299,520
$256.0 P/Share
|
|
Jan 03
2023
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-46.23%
|
$2,520,000
$252.95 P/Share
|
|
Jan 03
2023
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+49.25%
|
$0
$0.94 P/Share
|